CS logo
small CS logo
Southern California Institute For Respiratory Diseases, Inc.

Los Angeles, California, United States

About Southern California Institute For Respiratory Diseases, Inc.


  • Top Sponsors
  • Top Collaborators
  • Trials By Phase
  • Recruitment Status
  • Top Conditions
  • Intervention Types
  • Top Intervention Names
  • Trials By Gender

Clinical Trials at Southern California Institute For Respiratory Diseases, Inc.


During the past decade, Southern California Institute For Respiratory Diseases, Inc. conducted 14 clinical trials. In the 10-year time frame, 14 clinical trials started and 10 clinical trials were completed, i.e. on average, 71.4% percent of trials that started reached the finish line to date. In the past 5 years, 6 clinical trials started and 8 clinical trials were completed. i.e. 133.3% of trials that started reached the finish line.

Clinical Trials Sponsors and Collaborators


Out of the total clinical trials conducted in "Southern California Institute For Respiratory Diseases, Inc." #1 sponsor was "Jazz Pharmaceuticals" with 6 trials, followed by "Bellus Health Inc" with 2 trials sponsored, "Amphastar Pharmaceuticals, Inc." with 1 trials sponsored, "Array BioPharma" with 1 trials sponsored and "GB001, Inc, a wholly owned subsidiary of Gossamer Bio, Inc." with 1 trials sponsored. Other sponsors include 2 different institutions and companies that sponsored additional 12 trials in total.
In terms of collaborators to trials, out of the total clinical trials conducted in "Southern California Institute For Respiratory Diseases, Inc." #1 collaborator was "Iqvia Pty Ltd" with 1 trials as a collaborator and "LGC Limited" with 1 trials as a collaborator. Other collaborators include -2 different institutions and companies that were collaborators in the rest 2 trials.

Clinical Trials Conditions at Southern California Institute For Respiratory Diseases, Inc.


According to Clinical.Site data, the most researched conditions in "Southern California Institute For Respiratory Diseases, Inc." are "Asthma" (5 trials), "Narcolepsy" (4 trials), "COPD" (2 trials), "Obstructive Sleep Apnea" (2 trials) and "Refractory Chronic Cough" (2 trials). Many other conditions were trialed in "Southern California Institute For Respiratory Diseases, Inc." in a lesser frequency.

Clinical Trials Intervention Types at Southern California Institute For Respiratory Diseases, Inc.


Most popular intervention types in "Southern California Institute For Respiratory Diseases, Inc." are "Drug" (18 trials) and "Other" (1 trials). Other intervention types were less common.
The name of intervention was led by "Placebo" (8 trials), "JZP-110" (4 trials), "BLU-5937" (2 trials), "JZP-258" (2 trials) and "Placebo oral tablet" (2 trials). Other intervention names were less common.

Clinical Trials Genders at Southern California Institute For Respiratory Diseases, Inc.


The vast majority of trials in "Southern California Institute For Respiratory Diseases, Inc." are 18 trials for "All" genders.

Clinical Trials Status at Southern California Institute For Respiratory Diseases, Inc.


Currently, there are NaN active trials in "Southern California Institute For Respiratory Diseases, Inc.". undefined are not yet recruiting, 2 are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 16 completed trials in Southern California Institute For Respiratory Diseases, Inc., undefined suspended trials, and undefined terminated clinical trials to date.
Out of the total trials that were conducted in Southern California Institute For Respiratory Diseases, Inc., 0 "Phase 1" clinical trials were conducted, 9 "Phase 2" clinical trials and 9 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 1 trials, and there were also 0 trials that are defined as “Not Applicable".